Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
<p>Supplementary Figure S6. Distribution of HER2 gene ratio in relation to PIK3CA mutation status and HER2-enriched subtype.</p>
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
| _version_ | 1849927631993044992 |
|---|---|
| author | Jamunarani Veeraraghavan (16461809) |
| author2 | Carolina Gutierrez (14958125) Carmine De Angelis (16461812) Robert Davis (16461815) Tao Wang (14952136) Tomas Pascual (16461818) Pier Selenica (15052857) Katherine Sanchez (16461821) Hiroaki Nitta (16461824) Monesh Kapadia (16461827) Anne C. Pavlick (16461830) Patricia Galvan (16461833) Brent Rexer (16461836) Andres Forero-Torres (15053759) Rita Nanda (15034401) Anna M. Storniolo (16461839) Ian E. Krop (15029231) Matthew P. Goetz (8863130) Julie R. Nangia (15123189) Antonio C. Wolff (15017274) Britta Weigelt (15051465) Jorge S. Reis-Filho (15052878) Susan G. Hilsenbeck (14952139) Aleix Prat (14950504) C. Kent Osborne (15055636) Rachel Schiff (14958948) Mothaffar F. Rimawi (15055651) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Jamunarani Veeraraghavan (16461809) Carolina Gutierrez (14958125) Carmine De Angelis (16461812) Robert Davis (16461815) Tao Wang (14952136) Tomas Pascual (16461818) Pier Selenica (15052857) Katherine Sanchez (16461821) Hiroaki Nitta (16461824) Monesh Kapadia (16461827) Anne C. Pavlick (16461830) Patricia Galvan (16461833) Brent Rexer (16461836) Andres Forero-Torres (15053759) Rita Nanda (15034401) Anna M. Storniolo (16461839) Ian E. Krop (15029231) Matthew P. Goetz (8863130) Julie R. Nangia (15123189) Antonio C. Wolff (15017274) Britta Weigelt (15051465) Jorge S. Reis-Filho (15052878) Susan G. Hilsenbeck (14952139) Aleix Prat (14950504) C. Kent Osborne (15055636) Rachel Schiff (14958948) Mothaffar F. Rimawi (15055651) |
| author_role | author |
| dc.creator.none.fl_str_mv | Jamunarani Veeraraghavan (16461809) Carolina Gutierrez (14958125) Carmine De Angelis (16461812) Robert Davis (16461815) Tao Wang (14952136) Tomas Pascual (16461818) Pier Selenica (15052857) Katherine Sanchez (16461821) Hiroaki Nitta (16461824) Monesh Kapadia (16461827) Anne C. Pavlick (16461830) Patricia Galvan (16461833) Brent Rexer (16461836) Andres Forero-Torres (15053759) Rita Nanda (15034401) Anna M. Storniolo (16461839) Ian E. Krop (15029231) Matthew P. Goetz (8863130) Julie R. Nangia (15123189) Antonio C. Wolff (15017274) Britta Weigelt (15051465) Jorge S. Reis-Filho (15052878) Susan G. Hilsenbeck (14952139) Aleix Prat (14950504) C. Kent Osborne (15055636) Rachel Schiff (14958948) Mothaffar F. Rimawi (15055651) |
| dc.date.none.fl_str_mv | 2025-11-25T13:29:21Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30709369 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Figure_S6_from_A_Multiparameter_Molecular_Classifier_to_Predict_Response_to_Neoadjuvant_Lapatinib_plus_Trastuzumab_without_Chemotherapy_in_HER2_sup_sup_Breast_Cancer/30709369 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Biomarkers Prognostic biomarkers Breast Cancer |
| dc.title.none.fl_str_mv | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Supplementary Figure S6. Distribution of HER2 gene ratio in relation to PIK3CA mutation status and HER2-enriched subtype.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_3086bb99f68681b5bba442f0942fd0ed |
| identifier_str_mv | 10.1158/1078-0432.30709369 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30709369 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast CancerJamunarani Veeraraghavan (16461809)Carolina Gutierrez (14958125)Carmine De Angelis (16461812)Robert Davis (16461815)Tao Wang (14952136)Tomas Pascual (16461818)Pier Selenica (15052857)Katherine Sanchez (16461821)Hiroaki Nitta (16461824)Monesh Kapadia (16461827)Anne C. Pavlick (16461830)Patricia Galvan (16461833)Brent Rexer (16461836)Andres Forero-Torres (15053759)Rita Nanda (15034401)Anna M. Storniolo (16461839)Ian E. Krop (15029231)Matthew P. Goetz (8863130)Julie R. Nangia (15123189)Antonio C. Wolff (15017274)Britta Weigelt (15051465)Jorge S. Reis-Filho (15052878)Susan G. Hilsenbeck (14952139)Aleix Prat (14950504)C. Kent Osborne (15055636)Rachel Schiff (14958948)Mothaffar F. Rimawi (15055651)CancerCancer Detection and DiagnosisBiomarkersPrognostic biomarkersBreast Cancer<p>Supplementary Figure S6. Distribution of HER2 gene ratio in relation to PIK3CA mutation status and HER2-enriched subtype.</p>2025-11-25T13:29:21ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30709369https://figshare.com/articles/figure/Figure_S6_from_A_Multiparameter_Molecular_Classifier_to_Predict_Response_to_Neoadjuvant_Lapatinib_plus_Trastuzumab_without_Chemotherapy_in_HER2_sup_sup_Breast_Cancer/30709369CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307093692025-11-25T13:29:21Z |
| spellingShingle | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer Jamunarani Veeraraghavan (16461809) Cancer Cancer Detection and Diagnosis Biomarkers Prognostic biomarkers Breast Cancer |
| status_str | publishedVersion |
| title | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| title_full | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| title_fullStr | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| title_full_unstemmed | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| title_short | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| title_sort | Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer |
| topic | Cancer Cancer Detection and Diagnosis Biomarkers Prognostic biomarkers Breast Cancer |